Advancing S-Tensify™ Through Cell-Line-Specific Process Optimization
Samsung Biologics’ Minyong Eom, Hakyung Kim, Dongyoung Park, Sojeong Lee, and Daegyun Lee explain how cell-line-specific optimization of S-Tensify™ can reduce media consumption, increase titers, and shorten overall culture duration while expanding the flexibility of intensified fed-batch processing.